Translating knowledge of genetic disease mechanisms into gene therapies has been slow with limited clinical success. One major reason is that the transfer vectors, which are most often of viral origin ...
A new variation of the CRISPR-Cas9 gene editing system makes it easier to re-engineer massive quantities of cells for therapeutic applications. The approach, developed at Gladstone Institutes and UC ...
Governments around the world are making a big bet that the first vaccines for COVID-19 could be made with genetically engineered viruses. The engineered viruses, called adenoviral vectors, are ...
In a recent study posted to the bioRxiv* preprint server, researchers proposed rotavirus (RV)-based vaccine vectors with the potential for developing polyvalent vaccines targeting multiple enteric ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback